Patty Brisben Foundation For Women's Sexual Health Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2013
NCT02022722
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Patty Brisben Foundation For Women's Sexual Health

Active Ingredients

Drugs in Phase 4 Trials (3)

clobetasol (dermovate) (1 trial)

levobupivacaine (chirocaine) (1 trial)

triamcinolone (kenalog) (1 trial)

Drugs in Other Trials (1)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyspareunia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4